NIPH Clinical Trials Search

Study on the glucose-lowering effect and metabolic benefit of SGLT2 inhibitors

Basic Information

Recruitment status	Complete: follow-up complete
Health condition(s) or Problem(s) studied	Diabetes mellitus
Date of first enrollment	2020/08/05
Target sample size	60
Countries of recruitment	Japan
Study type	Observational
Intervention(s)

Outcome(s)

Primary Outcome	Changes in the levels of HbA1c.
Secondary Outcome	Changes in the levels of glycated albumin, fasting blood glucose, and urinary albumin/creatinine ratio.

Key inclusion & exclusion criteria

Age minimum	20years-old
Age maximum	80years-old
Gender	Male and Female
Include criteria
Exclude criteria	Exclusion criteria encompassed pregnant or breastfeeding women, patients with malignant disease, severe infections (including urinary tract infections), severe trauma, or recent surgery.